BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 10484524)

  • 1. Selective A2A adenosine receptor activation reduces ischemia-reperfusion injury in rat kidney.
    Okusa MD; Linden J; Macdonald T; Huang L
    Am J Physiol; 1999 Sep; 277(3):F404-12. PubMed ID: 10484524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective A(2A) adenosine receptor activation reduces skin pressure ulcer formation and inflammation.
    Peirce SM; Skalak TC; Rieger JM; Macdonald TL; Linden J
    Am J Physiol Heart Circ Physiol; 2001 Jul; 281(1):H67-74. PubMed ID: 11406470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A(2A) adenosine receptor-mediated inhibition of renal injury and neutrophil adhesion.
    Okusa MD; Linden J; Huang L; Rieger JM; Macdonald TL; Huynh LP
    Am J Physiol Renal Physiol; 2000 Nov; 279(5):F809-18. PubMed ID: 11053040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced protection from renal ischemia-reperfusion [correction of ischemia:reperfusion] injury with A(2A)-adenosine receptor activation and PDE 4 inhibition.
    Okusa MD; Linden J; Huang L; Rosin DL; Smith DF; Sullivan G
    Kidney Int; 2001 Jun; 59(6):2114-25. PubMed ID: 11380813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective adenosine-A2A activation reduces lung reperfusion injury following transplantation.
    Ross SD; Tribble CG; Linden J; Gangemi JJ; Lanpher BC; Wang AY; Kron IL
    J Heart Lung Transplant; 1999 Oct; 18(10):994-1002. PubMed ID: 10561110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic adenosine given after ischemia protects renal function via A(2a) adenosine receptor activation.
    Lee HT; Emala CW
    Am J Kidney Dis; 2001 Sep; 38(3):610-8. PubMed ID: 11532695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional and cytoarchitectural spinal cord protection by ATL-146e after ischemia/reperfusion is mediated by adenosine receptor agonism.
    Reece TB; Kron IL; Okonkwo DO; Laurent JJ; Tache-Leon C; Maxey TS; Ellman PI; Linden J; Tribble CG; Kern JA
    J Vasc Surg; 2006 Aug; 44(2):392-7. PubMed ID: 16890874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenosine and selective A(2A) receptor agonists reduce ischemia/reperfusion injury of rat liver mainly by inhibiting leukocyte activation.
    Harada N; Okajima K; Murakami K; Usune S; Sato C; Ohshima K; Katsuragi T
    J Pharmacol Exp Ther; 2000 Sep; 294(3):1034-42. PubMed ID: 10945856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effects of renal ischemic preconditioning and adenosine pretreatment: role of A(1) and A(3) receptors.
    Lee HT; Emala CW
    Am J Physiol Renal Physiol; 2000 Mar; 278(3):F380-7. PubMed ID: 10710542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardioprotective effects of adenosine A1 and A2A receptor agonists in the isolated rat heart.
    Lozza G; Conti A; Ongini E; Monopoli A
    Pharmacol Res; 1997 Jan; 35(1):57-64. PubMed ID: 9149317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenosine analogue reduces spinal cord reperfusion injury in a time-dependent fashion.
    Cassada DC; Tribble CG; Kaza AK; Fiser SM; Long SM; Linden J; Rieger JM; Kron IL; Kern JA
    Surgery; 2001 Aug; 130(2):230-5. PubMed ID: 11490354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An adenosine A2A agonist, ATL-146e, reduces paralysis and apoptosis during rabbit spinal cord reperfusion.
    Cassada DC; Tribble CG; Laubach VE; Nguyen BN; Rieger JM; Linden J; Kaza AK; Long SM; Kron IL; Kern JA
    J Vasc Surg; 2001 Sep; 34(3):482-8. PubMed ID: 11533601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenosine A2A analogue ATL-146e reduces systemic tumor necrosing factor-alpha and spinal cord capillary platelet-endothelial cell adhesion molecule-1 expression after spinal cord ischemia.
    Cassada DC; Tribble CG; Long SM; Laubach VE; Kaza AK; Linden J; Nguyen BN; Rieger JM; Fiser SM; Kron IL; Kern JA
    J Vasc Surg; 2002 May; 35(5):994-8. PubMed ID: 12021717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic adenosine A2A agonist ameliorates ischemic reperfusion injury in the rabbit spinal cord.
    Cassada DC; Gangemi JJ; Rieger JM; Linden J; Kaza AK; Long SM; Kron IL; Tribble CG; Kern JA
    Ann Thorac Surg; 2001 Oct; 72(4):1245-50. PubMed ID: 11603444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenosine A(2A) receptor stimulation reduces inflammation and neointimal growth in a murine carotid ligation model.
    McPherson JA; Barringhaus KG; Bishop GG; Sanders JM; Rieger JM; Hesselbacher SE; Gimple LW; Powers ER; Macdonald T; Sullivan G; Linden J; Sarembock IJ
    Arterioscler Thromb Vasc Biol; 2001 May; 21(5):791-6. PubMed ID: 11348876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of adenosine in renal protection induced by a brief episode of ischemic preconditioning in rats.
    Sugino H; Shimada H; Tsuchimoto K
    Jpn J Pharmacol; 2001 Oct; 87(2):134-42. PubMed ID: 11700012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenosine A2A receptor activation decreases reperfusion injury associated with high-flow reperfusion.
    Fiser SM; Tribble CG; Kaza AK; Long SM; Kern JA; Cassada DC; Linden J; Rieger J; Laubach VE; Matisoff A; Kron IL
    J Thorac Cardiovasc Surg; 2002 Nov; 124(5):973-8. PubMed ID: 12407381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid modification of the glycocalyx caused by ischemia-reperfusion is inhibited by adenosine A2A receptor activation.
    Platts SH; Linden J; Duling BR
    Am J Physiol Heart Circ Physiol; 2003 Jun; 284(6):H2360-7. PubMed ID: 12560210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenosine A2A agonist reduces paralysis after spinal cord ischemia: correlation with A2A receptor expression on motor neurons.
    Cassada DC; Tribble CG; Long SM; Kaza AK; Linden J; Rieger JM; Rosin D; Kron IL; Kern JA
    Ann Thorac Surg; 2002 Sep; 74(3):846-9; discussion 849-50. PubMed ID: 12238849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attenuation of renal ischemia-reperfusion injury by postconditioning involves adenosine receptor and protein kinase C activation.
    Eldaif SM; Deneve JA; Wang NP; Jiang R; Mosunjac M; Mutrie CJ; Guyton RA; Zhao ZQ; Vinten-Johansen J
    Transpl Int; 2010 Feb; 23(2):217-26. PubMed ID: 19725910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.